Consumer Healthcare Drug - Global and China Top Players Market Share and Ranking 2023
- Report Code : AMP2757529
- Published On: Oct, 2024
- Category : Healthcare & Pharma
- Pages : 155
-
According to Ample Market Research, the global market for Consumer Healthcare Drug should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Consumer Healthcare Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Consumer Healthcare Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospital grew percent to account for percent of the total market sales, and Retail Pharmacy grew percent.
Consumer health products are products sold directly to consumers. Unlike prescription drugs, selection and use of consumer health products does not require the oversight of a health care practitioner.
This report studies and analyses global Consumer Healthcare Drug status and future trends, to help determine the Consumer Healthcare Drug market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Consumer Healthcare Drug, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Consumer Healthcare Drug market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Consumer Healthcare Drug by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Consumer Healthcare Drug by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Consumer Healthcare Drug key consuming regions, consumption value and demand structure
(5) Consumer Healthcare Drug industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Johnson & Johnson
AbbVie
Merck & Co.
GlaxoSmithKline
Pfizer
Sanofi
Takeda
Bayer
Teva
Sinopharm Group
CR Pharmaceutical
Shanghai Pharmaceuticals
Hualan Bio
North China Pharmaceutical
Hengrui Medicine
Fosun Pharma
East China Medicine
Livzon Group
Market segment by Type, covers
Solid Preparations
Oral Liquid
Patch
Other
Market segment by Application, can be divided into
Hospital
Retail Pharmacy
Other
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Consumer Healthcare Drug product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Consumer Healthcare Drug market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Consumer Healthcare Drug market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Consumer Healthcare Drug industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
-
With tables and figures helping analyze worldwide Consumer Healthcare Drug Global and China Top Players market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Market Overview1.1 Consumer Healthcare Drug Definition
1.2 Global Consumer Healthcare Drug Market Size and Forecast
1.3 China Consumer Healthcare Drug Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Consumer Healthcare Drug Market Size: China VS Global Growth Rate, 2018-2029
1.6 Consumer Healthcare Drug Market Dynamics
1.6.1 Consumer Healthcare Drug Market Drivers
1.6.2 Consumer Healthcare Drug Market Restraints
1.6.3 Consumer Healthcare Drug Industry Trends
1.6.4 Consumer Healthcare Drug Industry Policy
2 Global Leading Players and Market Share2.1 By Revenue of Consumer Healthcare Drug, Global Market Share by Company, 2018-2023
2.2 Global Consumer Healthcare Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Consumer Healthcare Drug Concentration Ratio
2.4 Global Consumer Healthcare Drug Mergers & Acquisitions, Expansion Plans
2.5 Global Consumer Healthcare Drug Major Companies Product Type
2.6 Head Office and Consumer Healthcare Drug Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking3.1 By Revenue of Consumer Healthcare Drug, China Market Share by Company, 2018-2023
3.2 China Consumer Healthcare Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis4.1 Consumer Healthcare Drug Industry Chain
4.2 Consumer Healthcare Drug Upstream Analysis
4.2.1 Consumer Healthcare Drug Core Raw Materials
4.2.2 Main Manufacturers of Consumer Healthcare Drug Core Raw Materials4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Consumer Healthcare Drug Production Mode
4.6 Consumer Healthcare Drug Procurement Model
4.7 Consumer Healthcare Drug Industry Sales Model and Sales Channels
4.7.1 Consumer Healthcare Drug Sales Model
4.7.2 Consumer Healthcare Drug Typical Distributors
5 Sights by Type5.1 Consumer Healthcare Drug Classification
5.1.1 Solid Preparations
5.1.2 Oral Liquid
5.1.3 Patch
5.1.4 Other5.2 By Type, Global Consumer Healthcare Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Consumer Healthcare Drug Consumption Value, 2018-2029
6 Sights by Application6.1 Consumer Healthcare Drug Segment by Application
6.1.1 Hospital
6.1.2 Retail Pharmacy
6.1.3 Other6.2 By Application, Global Consumer Healthcare Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Consumer Healthcare Drug Consumption Value, 2018-2029
7 Sales Sights by Region7.1 By Region, Global Consumer Healthcare Drug Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Consumer Healthcare Drug Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Consumer Healthcare Drug & Forecasts, 2018-2029
7.3.2 By Country, North America Consumer Healthcare Drug Market Size Market Share7.4 Europe
7.4.1 Europe Consumer Healthcare Drug Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Consumer Healthcare Drug Market Size Market Share7.5 Asia Pacific
7.5.1 Asia Pacific Consumer Healthcare Drug Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Consumer Healthcare Drug Market Size Market Share7.6 South America
7.6.1 South America Consumer Healthcare Drug Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Consumer Healthcare Drug Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level8.1 By Country, Global Consumer Healthcare Drug Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Consumer Healthcare Drug Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Consumer Healthcare Drug Market Size, 2018-2029
8.3.2 By Type, U.S. Consumer Healthcare Drug Consumption Value Market Share, 2022 VS 2029
8.3.3 By Application, U.S. Consumer Healthcare Drug Consumption Value Market Share, 2022 VS 20298.4 Europe
8.4.1 Europe Consumer Healthcare Drug Market Size, 2018-2029
8.4.2 By Type, Europe Consumer Healthcare Drug Consumption Value Market Share, 2022 VS 2029
8.4.3 By Application, Europe Consumer Healthcare Drug Consumption Value Market Share, 2022 VS 20298.5 China
8.5.1 China Consumer Healthcare Drug Market Size, 2018-2029
8.5.2 By Type, China Consumer Healthcare Drug Consumption Value Market Share, 2022 VS 2029
8.5.3 By Application, China Consumer Healthcare Drug Consumption Value Market Share, 2022 VS 20298.6 Japan
8.6.1 Japan Consumer Healthcare Drug Market Size, 2018-2029
8.6.2 By Type, Japan Consumer Healthcare Drug Consumption Value Market Share, 2022 VS 2029
8.6.3 By Application, Japan Consumer Healthcare Drug Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Consumer Healthcare Drug Market Size, 2018-2029
8.7.2 By Type, South Korea Consumer Healthcare Drug Consumption Value Market Share, 2022 VS 2029
8.7.3 By Application, South Korea Consumer Healthcare Drug Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Consumer Healthcare Drug Market Size, 2018-2029
8.8.2 By Type, Southeast Asia Consumer Healthcare Drug Consumption Value Market Share, 2022 VS 2029
8.8.3 By Application, Southeast Asia Consumer Healthcare Drug Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Consumer Healthcare Drug Market Size, 2018-2029
8.9.2 By Type, India Consumer Healthcare Drug Consumption Value Market Share, 2022 VS 2029
8.9.3 By Application, India Consumer Healthcare Drug Consumption Value Market Share, 2022 VS 20298.10 Middle East & Africa
8.10.1 Middle East & Africa Consumer Healthcare Drug Market Size, 2018-2029
8.10.2 By Type, Middle East & Africa Consumer Healthcare Drug Consumption Value Market Share, 2022 VS 2029
8.10.3 By Application, Middle East & Africa Consumer Healthcare Drug Consumption Value Market Share, 2022 VS 2029
9 Company Profile9.1 Johnson & Johnson
9.1.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
9.1.2 Johnson & Johnson Company Profile and Main Business
9.1.3 Johnson & Johnson Consumer Healthcare Drug Models, Specifications and Application
9.1.4 Johnson & Johnson Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023
9.1.5 Johnson & Johnson Recent Developments9.2 AbbVie
9.2.1 AbbVie Company Information, Head Office, Market Area and Industry Position
9.2.2 AbbVie Company Profile and Main Business
9.2.3 AbbVie Consumer Healthcare Drug Models, Specifications and Application
9.2.4 AbbVie Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023
9.2.5 AbbVie Recent Developments9.3 Merck & Co.
9.3.1 Merck & Co. Company Information, Head Office, Market Area and Industry Position
9.3.2 Merck & Co. Company Profile and Main Business
9.3.3 Merck & Co. Consumer Healthcare Drug Models, Specifications and Application
9.3.4 Merck & Co. Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023
9.3.5 Merck & Co. Recent Developments9.4 GlaxoSmithKline
9.4.1 GlaxoSmithKline Company Information, Head Office, Market Area and Industry Position
9.4.2 GlaxoSmithKline Company Profile and Main Business
9.4.3 GlaxoSmithKline Consumer Healthcare Drug Models, Specifications and Application
9.4.4 GlaxoSmithKline Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023
9.4.5 GlaxoSmithKline Recent Developments9.5 Pfizer
9.5.1 Pfizer Company Information, Head Office, Market Area and Industry Position
9.5.2 Pfizer Company Profile and Main Business
9.5.3 Pfizer Consumer Healthcare Drug Models, Specifications and Application
9.5.4 Pfizer Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023
9.5.5 Pfizer Recent Developments9.6 Sanofi
9.6.1 Sanofi Company Information, Head Office, Market Area and Industry Position
9.6.2 Sanofi Company Profile and Main Business
9.6.3 Sanofi Consumer Healthcare Drug Models, Specifications and Application
9.6.4 Sanofi Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023
9.6.5 Sanofi Recent Developments
9.7 Takeda
9.7.1 Takeda Company Information, Head Office, Market Area and Industry Position
9.7.2 Takeda Company Profile and Main Business
9.7.3 Takeda Consumer Healthcare Drug Models, Specifications and Application
9.7.4 Takeda Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023
9.7.5 Takeda Recent Developments
9.8 Bayer
9.8.1 Bayer Company Information, Head Office, Market Area and Industry Position
9.8.2 Bayer Company Profile and Main Business
9.8.3 Bayer Consumer Healthcare Drug Models, Specifications and Application
9.8.4 Bayer Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023
9.8.5 Bayer Recent Developments
9.9 Teva
9.9.1 Teva Company Information, Head Office, Market Area and Industry Position
9.9.2 Teva Company Profile and Main Business
9.9.3 Teva Consumer Healthcare Drug Models, Specifications and Application
9.9.4 Teva Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023
9.9.5 Teva Recent Developments9.10 Sinopharm Group
9.10.1 Sinopharm Group Company Information, Head Office, Market Area and Industry Position
9.10.2 Sinopharm Group Company Profile and Main Business
9.10.3 Sinopharm Group Consumer Healthcare Drug Models, Specifications and Application
9.10.4 Sinopharm Group Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023
9.10.5 Sinopharm Group Recent Developments
9.11 CR Pharmaceutical
9.11.1 CR Pharmaceutical Company Information, Head Office, Market Area and Industry Position
9.11.2 CR Pharmaceutical Company Profile and Main Business
9.11.3 CR Pharmaceutical Consumer Healthcare Drug Models, Specifications and Application
9.11.4 CR Pharmaceutical Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023
9.11.5 CR Pharmaceutical Recent Developments
9.12 Shanghai Pharmaceuticals
9.12.1 Shanghai Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.12.2 Shanghai Pharmaceuticals Company Profile and Main Business
9.12.3 Shanghai Pharmaceuticals Consumer Healthcare Drug Models, Specifications and Application
9.12.4 Shanghai Pharmaceuticals Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023
9.12.5 Shanghai Pharmaceuticals Recent Developments
9.13 Hualan Bio
9.13.1 Hualan Bio Company Information, Head Office, Market Area and Industry Position
9.13.2 Hualan Bio Company Profile and Main Business
9.13.3 Hualan Bio Consumer Healthcare Drug Models, Specifications and Application
9.13.4 Hualan Bio Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023
9.13.5 Hualan Bio Recent Developments
9.14 North China Pharmaceutical
9.14.1 North China Pharmaceutical Company Information, Head Office, Market Area and Industry Position
9.14.2 North China Pharmaceutical Company Profile and Main Business
9.14.3 North China Pharmaceutical Consumer Healthcare Drug Models, Specifications and Application
9.14.4 North China Pharmaceutical Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023
9.14.5 North China Pharmaceutical Recent Developments
9.15 Hengrui Medicine
9.15.1 Hengrui Medicine Company Information, Head Office, Market Area and Industry Position
9.15.2 Hengrui Medicine Company Profile and Main Business
9.15.3 Hengrui Medicine Consumer Healthcare Drug Models, Specifications and Application
9.15.4 Hengrui Medicine Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023
9.15.5 Hengrui Medicine Recent Developments
9.16 Fosun Pharma
9.16.1 Fosun Pharma Company Information, Head Office, Market Area and Industry Position
9.16.2 Fosun Pharma Company Profile and Main Business
9.16.3 Fosun Pharma Consumer Healthcare Drug Models, Specifications and Application
9.16.4 Fosun Pharma Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023
9.16.5 Fosun Pharma Recent Developments
9.17 East China Medicine
9.17.1 East China Medicine Company Information, Head Office, Market Area and Industry Position
9.17.2 East China Medicine Company Profile and Main Business
9.17.3 East China Medicine Consumer Healthcare Drug Models, Specifications and Application
9.17.4 East China Medicine Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023
9.17.5 East China Medicine Recent Developments
9.18 Livzon Group
9.18.1 Livzon Group Company Information, Head Office, Market Area and Industry Position
9.18.2 Livzon Group Company Profile and Main Business
9.18.3 Livzon Group Consumer Healthcare Drug Models, Specifications and Application
9.18.4 Livzon Group Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023
9.18.5 Livzon Group Recent Developments
10 Conclusion
11 Appendix11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources11.3 Market Estimation Model
11.4 Disclaimer
-
The Consumer Healthcare Drug Global and China Top Players Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the Consumer Healthcare Drug Global and China Top Players Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
Consumer Healthcare Drug Global and China Top Players has a wide range of applications, including
The Consumer Healthcare Drug Global and China Top Players Market is expected to grow at a moderate CAGR during the forecast period of 2024 to 2029.
The convergence of various vital triggers, including a major slowdown in Western economies, and some critical points in globalization, leads to the transformation of business in the Consumer Healthcare Drug Global and China Top Players Market across the extensive corporate landscape.
In this highly competitive and rapidly evolving Consumer Healthcare Drug Global and China Top Players Industry, top strategic priorities such as innovation, diversification, and M&A would remain consistent.
